Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study

R.L. Hamers; R. Schuurman; PASER PharmAccess African Studies to Evaluate Resistance; T.F. de Wit

Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study

R.L. Hamers
, R. Schuurman
, PASER PharmAccess African Studies to Evaluate Resistance
, T.F. de Wit

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	307-317
Number of pages	11
Journal	The Lancet Infectious Diseases
Volume	12
Issue number	4
Publication status	Published - 2012

Access to Document

http://www.ncbi.nlm.nih.gov/pubmed?term=Effect%20of%20pretreatment%20HIV-1%20drug%20resistance%20on%20immunological%2C%20virological%2C%20and%20drug-resistance%20outcomes%20of%20first-line%20antiretroviral%20treatment%20in%20sub-Saharan%20Africa%3A%20a%20

Cite this

Hamers, R. L., Schuurman, R., PharmAccess African Studies to Evaluate Resistance, PASER., & de Wit, T. F. (2012). Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study. The Lancet Infectious Diseases, 12(4), 307-317. http://www.ncbi.nlm.nih.gov/pubmed?term=Effect%20of%20pretreatment%20HIV-1%20drug%20resistance%20on%20immunological%2C%20virological%2C%20and%20drug-resistance%20outcomes%20of%20first-line%20antiretroviral%20treatment%20in%20sub-Saharan%20Africa%3A%20a%20

@article{0707280b7ade45d59af495b3084ce655,

title = "Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study",

author = "R.L. Hamers and R. Schuurman and \{PharmAccess African Studies to Evaluate Resistance\}, PASER and \{de Wit\}, T.F.",

year = "2012",

language = "English",

volume = "12",

pages = "307--317",

journal = "The Lancet Infectious Diseases",

issn = "1473-3099",

publisher = "Elsevier Limited",

number = "4",

}

Hamers, RL, Schuurman, R, PharmAccess African Studies to Evaluate Resistance, PASER & de Wit, TF 2012, 'Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study', The Lancet Infectious Diseases, vol. 12, no. 4, pp. 307-317. <http://www.ncbi.nlm.nih.gov/pubmed?term=Effect%20of%20pretreatment%20HIV-1%20drug%20resistance%20on%20immunological%2C%20virological%2C%20and%20drug-resistance%20outcomes%20of%20first-line%20antiretroviral%20treatment%20in%20sub-Saharan%20Africa%3A%20a%20>

Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study. / Hamers, R.L.; Schuurman, R.; PharmAccess African Studies to Evaluate Resistance, PASER et al.
In: The Lancet Infectious Diseases, Vol. 12, No. 4, 2012, p. 307-317.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study

AU - Hamers, R.L.

AU - Schuurman, R.

AU - PharmAccess African Studies to Evaluate Resistance, PASER

AU - de Wit, T.F.

PY - 2012

Y1 - 2012

M3 - Article

SN - 1473-3099

VL - 12

SP - 307

EP - 317

JO - The Lancet Infectious Diseases

JF - The Lancet Infectious Diseases

IS - 4

ER -